Filing Details
- Accession Number:
- 0001722024-18-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-23 16:54:27
- Reporting Period:
- 2018-07-23
- Accepted Time:
- 2018-07-23 16:54:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1722024 | Alexandria Venture Investments, Llc | 385 East Colorado Blvd., Suite 299 Pasadena CA 91101 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-23 | 149,637 | $0.00 | 149,637 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2018-07-23 | 66,667 | $15.00 | 216,304 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B convertible preferred stock | Disposition | 2018-07-23 | 208,333 | $0.00 | 18,923 | $0.00 |
| Common Stock | Series D convertible preferred stock | Disposition | 2018-07-23 | 10,454 | $0.00 | 949 | $0.00 |
| Common Stock | Series E convertible preferred stock | Disposition | 2018-07-23 | 111,111 | $0.00 | 12,976 | $0.00 |
| Common Stock | Series E-1 convertible preferred stock | Disposition | 2018-07-23 | 285,714 | $0.00 | 25,952 | $0.00 |
| Common Stock | Series F convertible preferred stock | Disposition | 2018-07-23 | 1,000,000 | $0.00 | 90,837 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series B, Series D, Series E-1, and and Series F preferred stock was convertible into the Issuer's common stock at a ratio of 11.009 shares of preferred stock to 1 share of common stock, and converted automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- Each share of Series E preferred stock was convertible into the Issuer's common stock at a ratio of 8.5626 shares of preferred stock to 1 share of common stock, and converted automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- Not applicable.
Billionaire Hedge Funds
